Hardy-Abeloos C - Search Results

1

Radiation in Early-Stage Breast Cancer: Moving beyond an All or Nothing Approach.

Purswani JM, Hardy-Abeloos C, Perez CA, Kwa MJ, Chadha M, Gerber NK. Purswani JM, et al. Among authors: hardy abeloos c. Curr Oncol. 2022 Dec 23;30(1):184-195. doi: 10.3390/curroncol30010015. Curr Oncol. 2022. PMID: 36661664 Free PMC article. Review.

2

Disparities in the Uptake of Telemedicine and Implications for Clinical Trial Enrollment in Patients With Breast Cancer.

Hardy-Abeloos C, Karp J, Xiao J, Oh C, Barbee D, Maisonet O, Gerber N. Hardy-Abeloos C, et al. Int J Radiat Oncol Biol Phys. 2023 May 1;116(1):132-141. doi: 10.1016/j.ijrobp.2022.10.016. Epub 2022 Oct 21. Int J Radiat Oncol Biol Phys. 2023. PMID: 36273521 Free PMC article. Clinical Trial.

3

Radiation Recall Dermatitis after Donor Lymphocyte Infusion for Adult T-Cell Leukemia Lymphoma Post-Allogeneic Stem Cell Transplant.

Hardy-Abeloos C, Gerber N, Shaikh F. Hardy-Abeloos C, et al. Pract Radiat Oncol. 2023 May-Jun;13(3):179-182. doi: 10.1016/j.prro.2022.10.008. Epub 2022 Nov 5. Pract Radiat Oncol. 2023. PMID: 36347452

4

Repeat re-irradiation with interstitial HDR-brachytherapy for an in-field isolated nodal recurrence in a patient with HPV-positive squamous cell carcinoma of the head and neck.

Kim JK, Hardy-Abeloos C, Purswani JM, Kamen E, Concert CM, Duckworth T, Tam M, Haas J, Rybstein M, Vaezi A, Jacobson A, Hu KS. Kim JK, et al. Among authors: hardy abeloos c. Brachytherapy. 2023 Jul-Aug;22(4):503-511. doi: 10.1016/j.brachy.2022.12.003. Epub 2022 Dec 31. Brachytherapy. 2023. PMID: 36593130

5

Early effectiveness and toxicity outcomes of reirradiation after breast conserving surgery for recurrent or new primary breast cancer.

Hardy-Abeloos C, Xiao J, Oh C, Barbee D, Perez CA, Oratz R, Schnabel F, Axelrod D, Guth A, Braunstein LZ, Khan A, Choi JI, Gerber N. Hardy-Abeloos C, et al. Breast Cancer Res Treat. 2023 Feb;198(1):43-51. doi: 10.1007/s10549-022-06853-4. Epub 2023 Jan 5. Breast Cancer Res Treat. 2023. PMID: 36604352

6

[No title available]

[No authors listed] [No authors listed] PMID: 37784794

7

Stereotactic body radiation therapy for centrally located hepatocellular carcinoma: outcomes and toxicities.

Lazarev S, Hardy-Abeloos C, Factor O, Rosenzweig K, Buckstein M. Lazarev S, et al. J Cancer Res Clin Oncol. 2018 Oct;144(10):2077-2083. doi: 10.1007/s00432-018-2729-y. Epub 2018 Aug 7. J Cancer Res Clin Oncol. 2018. PMID: 30088143

8

Safety and Efficacy of Liver Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma After Segmental Transarterial Radioembolization.

Hardy-Abeloos C, Lazarev S, Ru M, Kim E, Fischman A, Moshier E, Rosenzweig K, Buckstein M. Hardy-Abeloos C, et al. Int J Radiat Oncol Biol Phys. 2019 Dec 1;105(5):968-976. doi: 10.1016/j.ijrobp.2019.09.006. Epub 2019 Sep 16. Int J Radiat Oncol Biol Phys. 2019. PMID: 31536781

9

Ibrutinib dose modifications in the management of CLL.

Hardy-Abeloos C, Pinotti R, Gabrilove J. Hardy-Abeloos C, et al. J Hematol Oncol. 2020 Jun 5;13(1):66. doi: 10.1186/s13045-020-00870-w. J Hematol Oncol. 2020. PMID: 32503582 Free PMC article. Review.

10

Characterization of rib fracture development following liver directed stereotactic body radiation therapy.

Hardy-Abeloos C, Lehrer EJ, Nehlsen AD, Sindhu KK, Rowley JP, Sheu R, Rosenzweig KE, Buckstein M. Hardy-Abeloos C, et al. J Radiosurg SBRT. 2022;8(2):109-116. J Radiosurg SBRT. 2022. PMID: 36275138 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page